retatrutide clinical trials safety data is getting a lot of attention, and for good reason. Early looks promising, but it's still in and not FDA-approved Retatrutide study sees significant weight

Search strategy and study selection We conducted a comprehensive search through PubMed, Scopus, and Web of Science databases to identify pertinent studies from their inception until March 2024

If your vial has been exposed to temperatures above 30 degrees Celsius for more than a few hours, assume significant potency loss

When to consider switching medications If one GLP-1 medication is not producing results after adequate time at therapeutic doses, switching may be worth exploring

Another 2024 study said the weight loss benefits were similar between oral and injectable versions

Wootten, D., Simms, J., Miller, L

The 2024 AAFPRS member survey documented a 50% increase in facial fat grafting procedures, driven largely by GLP-1 patients